StockUpTicks Launches FREE Stock Research Service: Coverage Initiated on Viropro, Inc. (OTCBB:VPRO)

Dear Reader:

It’s an uncertain world some say, and the markets are no different. We struggle to make sense of the complexities through intuition, common sense, and trusted sources while the unusual seems to be the norm of late.  Martha Stewart’s likely headed to jail, the TYCO jury’s behaving like characters from a Grisham novel, and hold on to your hats… the Dow’s kicking companies out of its elite fraternity.

What does an investor do when the stock market seems poised for a return to greatness while simultaneous events like the aforementioned make you wonder about what can be counted on? 

Turn to research, we say - solid research from trusted sources.  You can’t trust Internet chat room blather or spam stock touts that tell you a stock is going up (that’s why we never do it), but we believe today’s guest analyst is supremely qualified to provide honest, in-depth research - as he leads off this new service offering with a report on Viropro, Inc. 

Many of you will recognize Francis Gaskins of IPOdesktop as he’s long been our radio interviewer for all our “CEO Access” interviews.  Now we’ve enlisted his tremendous knowledge and experience to put together due diligence with his analytical spin on companies we feature.  We think you’ll enjoy this FREE value-added service from your old friend StockUpTicks as Francis Gaskins initiates coverage on Viropro, Inc. (OTCBB: VPRO).
 
 
 

**Research Report on Viropro, Inc. - by Analyst Francis Gaskins**

 

Healthcare software -- "...essentially the only company in Canada to offer case-costing as an off-the-shelf, cross-platform, low risk and minimally intrusive software solution."
*Find out why that's important within a "socialized medicine" framework.

Life science and biotech initiatives
*Find out why Brazil is the portal launch point for generic drug and technology transfer initiatives.

Click Here to read this exciting, FREE research report on Viropro!

Analyst Francis Gaskins sat down with Viropro President Robert Egery to talk about Viropro's innovative growth strategy. 

Click Here to listen to the interview (March 31, 2004).

Click Here to read StockUpTicks' 3/19/04 company profile on Viropro 
 
 

About Viropro Inc.

Viropro is an emerging provider of  management, product and technology solutions for the international Life Sciences markets.  One mission of the Company is to seek revenue-producing acquisition targets with the goal of establishing a new growth portfolio and a potential for continued shareholder value. On December 18, 2003, this culminated in a Letter of Intent to acquire CNC Holdings Inc.  Headquartered in Montreal, Canada, CNC Holdings Inc. develops and markets proven, innovative management solutions for the healthcare sector. 

The acquisition of CNC will immediately propel Viropro into two fast-growing segments of the life sciences market – healthcare and biotech. Other acquisitions and alliances are also contemplated in coming months. This acquisition will be concluded upon the completion of due diligence and the final confirmation of the S-4 Registration Statement that was filed with the SEC in February 2004.

The other mission at Viropro is the discovery and development of chemical and biological products and processes that will benefit medical science and increase the quality of life.

Viropro Financial Highlights

To Contact Viropro

---

*** The Bull is Running. ***
There may never be a better time to feature YOUR company
to over 1 MILLION investors.

To learn more about our programs email us directly at info@stockupticks.com

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness.  Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP has been compensated $17,500 by VPRO for preparation and distribution of this report and other advertising services.  This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company.  Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934 - Market Pathways 1920 Main Street, Suite 980, Irvine, CA  92614.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.